Trial Profile
A Randomized, Evaluator-Blind, Placebo-Controlled, Parallel-Group Dose-Ranging Exploratory Study of the Safety and Efficacy of Oral R115866 vs. R115866 Placebo in the Treatment of Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2019
Price :
$35
*
At a glance
- Drugs Talarozole (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Barrier Therapeutics Inc
- 04 Aug 2019 Status changed from recruiting to completed.
- 12 May 2011 New trial record